19-Jan-2021 | Market Research Store
Recently, a team from the University of Toronto's Institute has found statins which are common cholesterol-lowering medications to help protect the heart of women undergoing chemotherapy for early-stage breast cancer. According to the lead researcher Husam Abdel-Qadir, their article published in the Journal of the American Heart Association clearly explains the risks of cancer medications such as anthracyclines and trastuzumab on the breast cancer patients as these drugs are found to affect the heart muscles. Furthermore, the age and other health problems of these women are also found to increase their chances of risks.
Even though the medications are designed to kill the breast cancer cells there are chances that these processes can also damage the cells of the heart muscle and in the long weaken the heart. There was a study conducted that showed the women on statins had no heart muscle damage even while undergoing any kind of chemotherapy. However, the exact mechanism of how statin avoids the cardiac cell damage is still unclear. It is believed that the statins have antioxidative and anti-inflammatory actions that are used to prevent heart failure in patients receiving chemotherapy. The researchers are now trying to find an effective correlation between statins and a lower risk of heart failure.
It cannot be conclusively proved that statins are protective in nature as the study requires more evidence to support the hypothesis. Statins are normally advised to be taken throughout the chemotherapy by women with breast cancer. The women with breast cancer are currently being forced to focus on measures to standardize their cardiovascular health before, during, and after chemotherapy. The researchers are now trying to study the effect of statins based on the heart's pumping ability and heart biomarkers. Thus, as the limitations are endless and so are the demographic changes, there are a lot of studies required to be done for providing reliable data.
Market Research Store has published a report on global statins market. This report incorporates all the microscopic and macroscopic details of the statin industry which can have an impact on the future growth rate.